|
Device report from japan reports an event as follows: it was reported that on (b)(6) 2022, the patient underwent orif for clavicular diaphysis with the products in question.Two months later on (b)(4) 2022, it backed out.The doctor has confirmed by x-ray that there are no broken pieces or other residuals in the body.No further information is available.This report is for a 2.7mm ti va lcp clavicle plate shaft/ cs1/ right/ sterile.This is report 1 of 2 for (b)(4).
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Additional narrative: a manufacturing record evaluation was performed for the finished article lot and no non-conformances were identified.Part: 04.112.621s, lot no: 735p722, release to warehouse date: 25 march 2022, expiry date: 01 march 2032, manufacturing site: werk selzach, supplier: synthes usa hq, inc.Product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Complainant part is not expected to be returned for manufacturer review/investigation.Initial reporter is a synthes employee.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|